Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dacarbazine × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 51 Lymphoid 26 Sarcoma 10 CNS 2 Thoracic 1 Other solid neoplasm 1 Head & Neck 1 Endocrine 1

Conditions

Interventions

Cisplatin 73 Gemcitabine 54 Carboplatin 53 Irinotecan 50 Paclitaxel 49 Pemetrexed 40 Docetaxel 33 Nivolumab 28 Fluorouracil 26 Bevacizumab 24 Cyclophosphamide 22 Capecitabine 22 Oxaliplatin 19 Leucovorin 18 pembrolizumab 17 Topotecan 17 Sorafenib 16 Erlotinib Hydrochloride 16 Ipilimumab 15 Etoposide 15 Bortezomib 15 Everolimus 14 Early Intervention, Educational 14 durvalumab 13 Sunitinib 13 Sirolimus 13 atezolizumab 12 Temozolomide 12 Taxes 12 Injections 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05898451 2023-06-12

R-2

Refnot-Pharm Ltd

Phase 2 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡